Medigen Biotechnology Corp.
3176.TWO
Price:
$31.55
Market Cap:
$4.40B
Medigen Biotechnology Corp., a biopharmaceutical company, focuses on the development of therapies for liver diseases and cancers in Taiwan. It offers cell therapies, such as MAGICELL-NK, which are natural killer cells; and MAGICELL-GDT, which are T cells. It also develops OBP-301 that has completed Phase I clinical trials in combination with esophageal cancer in Japan; is in Phase I clinical trials in combination with immune checkpoint inhibitors (ICI) for patients with esophageal cancer in Japan; and in phase II study in combination with ICI for esophageal cancer and gastric cancer patients in the United States. Medigen Biotechnology Corp. was founded in 1999 and is headquartered in Taipei,...[Read more]
Industry
Biotechnology
IPO Date
2007-12-31
Stock Exchange
TWO
Ticker
3176.TWO
PE Ratio
[-41.51]
ROE
[-6.42%]
Current Ratio
[5.12]
Dividend Yield
[0%]
Enterprise Value
[4.47B]
Dividend History
The ROE as of December 2025 (TTM) for Medigen Biotechnology Corp. (3176.TWO) is -6.42%
According to Medigen Biotechnology Corp.’s latest financial reports and current stock price. The company's current ROE is -6.42%. This represents a change of 276.82% compared to the average of -1.70% of the last 4 quarters.
Medigen Biotechnology Corp. (3176.TWO) Historical ROE (quarterly & annually)
How has 3176.TWO ROE performed in the past?
The mean historical ROE of Medigen Biotechnology Corp. over the last ten years is -22.07%. The current -6.42% ROE has changed -70.90% with respect to the historical average. Over the past ten years (40 quarters), 3176.TWO's ROE was at its highest in in the March 2025 quarter at 6.08%. The ROE was at its lowest in in the December 2023 quarter at -20.24%.
Average
-22.07%
Median
-25.40%
Minimum
-35.27%
Maximum
-2.20%
Medigen Biotechnology Corp. (3176.TWO) ROE by Quarter and Year
Discovering the peaks and valleys of Medigen Biotechnology Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.30%
Maximum Annual ROE = -2.20%
Minimum Annual Increase = -88.20%
Minimum Annual ROE = -35.27%
| Year | ROE | Change |
|---|---|---|
| 2024 | -12.94% | -63.31% |
| 2023 | -35.27% | 14.48% |
| 2022 | -30.81% | 1.30% |
| 2021 | -2.20% | -88.20% |
| 2020 | -18.61% | -0.92% |
| 2019 | -18.79% | -34.76% |
| 2018 | -28.80% | 13.36% |
| 2017 | -25.40% | -1.60% |
Medigen Biotechnology Corp. (3176.TWO) Average ROE
How has 3176.TWO ROE performed in the past?
The current ROE of Medigen Biotechnology Corp. (3176.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-26.34%
5-year avg
-19.96%
10-year avg
-22.07%
Medigen Biotechnology Corp. (3176.TWO) ROE vs. Peers
How is 3176.TWO’s ROE compared to its peers?
Medigen Biotechnology Corp.’s ROE is greater than Senhwa Biosciences, Inc. (-28.27%), greater than UnicoCell Biomed Co., Ltd. (-12.58%), greater than BRIM Biotechnology, Inc. (-11.90%), greater than Energenesis Biomedical CO.,LTD. (-25.31%), greater than Formosa Pharmaceuticals, Inc. (-4.84%), greater than AnnJi (-54.10%), greater than TWi Biotechnology, Inc. (-69.83%), less than Synbio Tech Inc. (13.55%), greater than Shine-On BioMedical Co.,Ltd. (-11.76%), greater than Sagittarius Life Science Corp (-6.34%),
| Company | ROE | Market cap |
|---|---|---|
| -28.27% | $3.72B | |
| -12.58% | $4.78B | |
| -11.90% | $3.85B | |
| -25.31% | $3.81B | |
| -4.84% | $4.02B | |
| -54.10% | $4.86B | |
| -69.83% | $1.77B | |
| 13.55% | $3.08B | |
| -11.76% | $3.39B | |
| -6.34% | $3.43B |
Build a custom stock screener for Medigen Biotechnology Corp. (3176.TWO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Medigen Biotechnology Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Medigen Biotechnology Corp. (3176.TWO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Medigen Biotechnology Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Medigen Biotechnology Corp.'s ROE?
How is the ROE calculated for Medigen Biotechnology Corp. (3176.TWO)?
What is the highest ROE for Medigen Biotechnology Corp. (3176.TWO)?
What is the 3-year average ROE for Medigen Biotechnology Corp. (3176.TWO)?
What is the 5-year average ROE for Medigen Biotechnology Corp. (3176.TWO)?
How does the current ROE for Medigen Biotechnology Corp. (3176.TWO) compare to its historical average?